JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB272456

Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade

  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • What is this?

3

(1 Review)

|

(13 Publications)

Rabbit Recombinant Monoclonal RUNX1 / AML1 antibody. Suitable for ChIC/CUT&RUN-seq, IP, ChIP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 13 publications.

View Alternative Names

AML1, CBFA2, RUNX1, Runt-related transcription factor 1, Acute myeloid leukemia 1 protein, Core-binding factor subunit alpha-2, Oncogene AML-1, Polyomavirus enhancer-binding protein 2 alpha B subunit, SL3-3 enhancer factor 1 alpha B subunit, SL3/AKV core-binding factor alpha B subunit, CBF-alpha-2, PEA2-alpha B, PEBP2-alpha B

6 Images
Flow Cytometry (Intracellular) - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

Intracellular flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized Jurkat (Human T cell leukemia T lymphocyte) cells labelling RUNX1 / AML1 with ab272456 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • IP

Lab

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

RUNX1 / AML1 was immunoprecipitated from K562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate with ab272456 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab272456 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : K562 whole cell lysate 10 μg

Lane 2 : ab272456 IP in K562 whole cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab272456 in K562 whole cell lysate

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : 3 mins.

All lanes:

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (ab272456)

Predicted band size: 48 kDa

false

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • IP

Unknown

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

RUNX1 / AML1 was immunoprecipitated from 0.35 mg Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate with ab272456 at 1/30 dilution. Western blot was performed on the immunoprecipitate using ab272456 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.

Lane 1 : Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate 20 ug

Lane 2 : ab272456 IP in Jurkat whole cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab272456 in Jurkat whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 32 seconds.

All lanes:

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (ab272456)

Predicted band size: 48 kDa

Observed band size: 27-38 kDa

false

ChIP - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • ChIP

Supplier Data

ChIP - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

Chromatin was prepared from K-562 cells according to the Abcam Dual-X-ChIP protocol. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min.
The ChIP was performed with 25 μg of chromatin, 5 μg of ab272456 (red), or 5 μg of rabbit normal IgG ab172730 (gray) and 20 μl of Protein A/G sepharose beads. The immunoprecipitated DNA was quantified by real time PCR (Taqman approach for active and inactive loci, Sybr green approach for heterochromatic loci).
Primers and probes are from paper PMID:20959602

The RUNX1 enrichment profile is consistent with what have been described in literature (PMID : 20959602).

Western blot - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • WB

Lab

Western blot - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

RUNX1 has several isoforms. The molecular weight observed is consistent with what have been described in literature (PMID : 17431130, 29296779).

Exposure time : 3 minutes

All lanes:

Western blot - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (ab272456) at 1/1000 dilution

Lane 1:

Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Lane 2:

MOLT-4 (human lymphoblastic leukemia t lymphoblast) whole cell lysate at 20 µg

Lane 3:

THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 48 kDa

Observed band size: 27-48 kDa

false

ChIC/CUT&RUN sequencing - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade (AB272456)

ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (Human chronic myelogenous leukemia lymphoblast) cells and 5µg of ab272456 [EPR23309-113]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Support and downloads section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-RUNX1 / AML1 antibody [EPR23309-113] - ChIP Grade - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR23309-113

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt (Intra), ChIC/CUT&RUN-seq, IP, ChIP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "5 µg", "ChICCUTRUNseq-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "5 µg for 25 µg chromatin", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "ChICCUTRUNseq-species-checked": "notRecommended", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" }, "Rat": { "ChICCUTRUNseq-species-checked": "notRecommended", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RUNX1 also known as AML1 is a transcription factor with a molecular weight of approximately 48 kDa. It belongs to the Runt-related transcription factor family and plays a critical role in hematopoiesis. RUNX1 is expressed in hematopoietic stem cells and various other tissues where it regulates the expression of genes involved in the differentiation and proliferation of blood cells. It exerts its function by binding to specific DNA sequences thereby controlling the transcriptional activity necessary for normal hematopoietic development.
Biological function summary

RUNX1 is essential in the formation of blood cells and is part of the core-binding factor (CBF) complex. This complex is a heterodimer comprising RUNX1 and the CBFβ subunit. The interaction between RUNX1 and CBFβ stabilizes the DNA binding capability of RUNX1 facilitating the activation of target gene transcription. The proper functioning of RUNX1 is necessary for the maintenance of normal lineage specification of hematopoietic progenitors affecting both myeloid and lymphoid cell lineages.

Pathways

RUNX1 plays a significant role in the Wnt signaling pathway and the TGF-beta signaling pathway. RUNX1 interacts with several proteins in these pathways including SMAD proteins and β-catenin which are important for transmitting extracellular signals that regulate cell growth and differentiation. RUNX1’s role in these pathways highlights its importance not only in hematopoiesis but also in preventing abnormal cell proliferation.

RUNX1 mutations are strongly associated with acute myeloid leukemia (AML) and familial platelet disorder. In AML RUNX1 mutations disrupt normal hematopoiesis leading to the uncontrolled proliferation of immature blood cells. RUNX1-related proteins such as the GM-CSF receptor can contribute to disease progression by altering cytokine signaling. RUNX1's involvement in familial platelet disorder reflects its importance in maintaining normal blood cell counts and function as loss of RUNX1 function leads to predisposition to leukemia.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (Probable). Essential for the development of normal hematopoiesis (PubMed : 17431401). Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter (PubMed : 10207087, PubMed : 14970218). Inhibits KAT6B-dependent transcriptional activation (By similarity). Involved in lineage commitment of immature T cell precursors. CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. CBF complexes binding to the transcriptional silencer is essential for recruitment of nuclear protein complexes that catalyze epigenetic modifications to establish epigenetic ZBTB7B silencing (By similarity). Controls the anergy and suppressive function of regulatory T-cells (Treg) by associating with FOXP3. Activates the expression of IL2 and IFNG and down-regulates the expression of TNFRSF18, IL2RA and CTLA4, in conventional T-cells (PubMed : 17377532). Positively regulates the expression of RORC in T-helper 17 cells (By similarity).. Isoform AML-1G shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation.. Isoform AML-1L interferes with the transactivation activity of RUNX1.
See full target information RUNX1

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Cell biology and toxicology 41:21 PubMed39753834

2025

Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yunhao Wu,Nu Li,Jin Shang,Jiazi Jiang,Xiaoliang Liu

The EMBO journal 43:6291-6309 PubMed39543396

2024

Redistribution of PU.1 partner transcription factor RUNX1 binding secures cell survival during leukemogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Alexander Bender,Füsun Boydere,Ashok Kumar Jayavelu,Alessia Tibello,Thorsten König,Hanna Aleth,Gerd Meyer Zu Hörste,Thomas Vogl,Frank Rosenbauer

Nature communications 15:9286 PubMed39468077

2024

Epigenetic memory of radiotherapy in dermal fibroblasts impairs wound repair capacity in cancer survivors.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaowei Bian,Minna Piipponen,Zhuang Liu,Lihua Luo,Jennifer Geara,Yongjian Chen,Traimate Sangsuwan,Monica Maselli,Candice Diaz,Connor A Bain,Evelien Eenjes,Maria Genander,Michael Crichton,Jenna L Cash,Louis Archambault,Siamak Haghdoost,Julie Fradette,Pehr Sommar,Martin Halle,Ning Xu Landén

World journal of stem cells 16:538-550 PubMed38817334

2024

GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines.

Applications

Unspecified application

Species

Unspecified reactive species

Yang-Zhou Jiang,Lan-Yue Hu,Mao-Shan Chen,Xiao-Jie Wang,Cheng-Ning Tan,Pei-Pei Xue,Teng Yu,Xiao-Yan He,Li-Xin Xiang,Yan-Ni Xiao,Xiao-Liang Li,Qian Ran,Zhong-Jun Li,Li Chen

Cell communication and signaling : CCS 22:227 PubMed38610001

2024

RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Qingwen Zhu,Xinyu Zhang,Fei Lu,Siyu Miao,Chunyang Zhang,Zhenzhen Liu,Zejun Gao,Meihao Qi,Xiaogang An,Panling Geng,Sufang Wang,Hongbo Ren,Fugen Han,Ruyue Zhang,DingJun Zha

Molecules and cells 46:219-230 PubMed36625318

2023

RUNX1 Upregulation Causes Mitochondrial Dysfunction via Regulating the PI3K-Akt Pathway in iPSC from Patients with Down Syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Yanna Liu,Yuehua Zhang,Zhaorui Ren,Fanyi Zeng,Jingbin Yan

Molecules and cells 46:231-244 PubMed36625319

2023

RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Ding,Xiaoliang Mei,Lintao Li,Peng Fang,Ting Guo,Jianning Zhao

Cell death discovery 8:404 PubMed36182925

2022

Sevoflurane induces microRNA-18a to delay rat neurodevelopment via suppression of the RUNX1/Wnt/β-catenin axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yuge Jiang,Yaobo Liu,Yuhui Sun,Yongzhe Liu,Long Feng,Mingda Duan,Yi Liu,Longhe Xu

iScience 25:104936 PubMed36072549

2022

Activation of GDNF-ERK-Runx1 signaling contributes to P2X3R gene transcription and bone cancer pain.

Applications

Unspecified application

Species

Unspecified reactive species

Zhu-Lin Yuan,Xiao-Dan Liu,Zi-Xian Zhang,Song Li,Yue Tian,Ke Xi,Jie Cai,Xiao-Mei Yang,Min Liu,Guo-Gang Xing

Gland surgery 11:868-881 PubMed35694090

2022

Bioinformatics analysis of downstream circRNAs and miRNAs regulated by Runt-related transcription factor 1 in papillary thyroid carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jiajie Xu,Guowan Zheng,Haiwei Guo,Kexin Meng,Wanchen Zhang,Ru He,Chuanming Zheng,Minghua Ge
View all publications
chicCutRunSequencingBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com